Recent advances in the drug discovery of metabotropic glutamate receptor 4 (mGluR4) activators for the treatment of CNS and non-CNS disorders

Author： Célanire Sylvain   Campo Brice  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.7, Iss.3, 2012-03, pp. : 261-280

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the Metabotropic Glutamate Receptor mGluR4 for the Treatment of Diseases of the Central Nervous System

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 9, 2005-08 ,pp. : 885-895

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 (mGluR5)

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 9, 2005-08 ,pp. : 825-846

Bentham Science Publishers

Access to resources Recommend Favorite

In Vivo Imaging of the Metabotropic Glutamate Receptor 1 (mGluR1) with Positron Emission Tomography: Recent Advance and Perspective

By  

Current Medicinal Chemistry, Vol. 21, Iss. 1, 2014-01 ,pp. : 113-123

Bentham Science Publishers

Access to resources Recommend Favorite

Metabotropic Glutamate Receptor 7 (mGluR7) as a Target for the Treatment of Psychostimulant Dependence

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 6, 2015-01 ,pp. : 738-744

Bentham Science Publishers

Access to resources Recommend Favorite

Metabotropic glutamate receptor 4 (mGlu4)-positive allosteric modulators for the treatment of Parkinson's disease: historical perspective and review of the patent literature

By Lindsley Craig W   Hopkins Corey R  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 5, 2012-05 ,pp. : 461-481

Informa Healthcare

Access to resources Recommend Favorite